NovaSeq X Series 25B Reagent Kits

The National Institutes of Health intends to award a Firm-Fixed-Price Purchase Order to Illumina Inc. for the provision of NovaSeq X Series 25B Reagent Kits. The purpose of this acquisition is to provide supplies to the Neurodegenerative Diseases Research Unit for research on sequencing DNA samples using Illumina-manufactured NovaSeq sequencing systems. • The reagents must be compatible with and perform optimally in the Illumina-manufactured systems. • The acquisition is for the use of proprietary reagents to ensure efficient operation and desired outcomes of the operating systems. • Small businesses may submit a written capability statement to demonstrate their ability to perform the requirement. • The Government may determine to compete this proposed award based on responses to the notice.